U.S. Food Stock News

BioNTech, NasdaqGS:BNTX, faces potential U.S. pharmaceutical tariffs that could affect access to a key market. The company is preparing for the announced departures of its co founders from leadership roles. These developments arrive while the share price stands at $97.54 and recent returns show mixed performance across different time frames. For investors watching NasdaqGS:BNTX, these leadership changes and tariff risks are landing on a share price of $97.54, with recent moves including a...

Semtech (SMTC) is back in focus after analysts highlighted its recent track record of exceeding earnings estimates and a current positive Earnings ESP, with supportive ratings indicating firm expectations for its upcoming results. See our latest analysis for Semtech. At a share price of $107.81, Semtech has seen a 30 day share price return of 34.7% and a year to date share price return of 43.25%. Its 1 year total shareholder return of 215.88% and 3 year total shareholder return of close to 5x...

CCC Intelligent Solutions Holdings launched mobile invoice scanning in the CCC ONE platform, integrating directly into its repair management workflow. The new feature uses AI to match invoice line items to repair orders, automating parts reconciliation for repair shops. The capability is available at no additional cost to users of CCC ONE, aiming to cut manual data entry and reduce processing time. CCC Intelligent Solutions Holdings, traded as NasdaqGS:CCC, is rolling out this product...

If you are wondering whether Teradata is attractively priced or looking stretched at its current levels, you will want to understand what the valuation numbers are actually saying. The stock last closed at US$27.96, with returns of 5.8% over the past week, 10.8% over the past month, a 5.8% decline year to date, and 26.7% over the last year, alongside weaker 3 year and 5 year returns of 37.2% and 31.0% respectively. These mixed returns have kept Teradata on the radar for investors who pay...

In April 2026, Park National Corporation reported first-quarter 2026 results showing higher net interest income of US$125.78 million but slightly lower net income of US$41.69 million and earnings per share, alongside a quarterly dividend declaration of US$1.10 per share. The quarter also featured a rise in net charge-offs to US$2.63 million from US$592,000 a year earlier, putting asset quality trends in sharper focus for investors. We’ll now look at how the mix of rising net interest income...

In April 2026, Agree Realty Corporation completed roughly US$1.00 billion of follow-on common equity offerings and filed an additional US$1.75 billion at-the-market equity program alongside a new universal shelf registration covering common and preferred stock, depositary shares, warrants, and debt securities. This combination of fresh equity capital and expanded shelf capacity signals that Agree Realty is preparing for a potentially larger, more flexible funding toolkit to support its...

Garmin (NYSE:GRMN) reports record Q1 2026 revenue and operating income, setting new highs for the company. Fitness segment revenue rises 42% in Q1 2026, supported by advanced wearables and recent product launches. Garmin plans around 100 product launches in 2026 across its diversified segments. The company secures multiple new EASA certifications for aviation equipment, expanding its presence in the European market. For investors tracking consumer electronics and aerospace, Garmin sits at...

Banco Latinoamericano de Comercio Exterior S. A. gained shareholder approval at its recent Annual Shareholders' Meeting to change its legal name to Bladex Inc. The rebranding will shift the company’s official identity while it continues to trade on the NYSE under ticker NYSE:BLX. The name change is expected to influence how the bank presents itself to clients, investors, and counterparties across Latin America and beyond. The rebrand to Bladex Inc. comes at a time when NYSE:BLX shares are...

NovoCure (NasdaqGS:NVCR) received FDA approval for Optune Pax for locally advanced pancreatic cancer and has started its U.S. commercial launch. The new therapy has seen early adoption and payer coverage in the U.S., expanding NovoCure's reach beyond its original focus in glioblastoma. Pivotal Phase 3 data from the TRIDENT trial in newly diagnosed glioblastoma are expected later this year. NovoCure focuses on tumor treating fields therapy, a medical technology designed to disrupt cancer...

Ocular Therapeutix recently enrolled the first patient in its SOL-X long-term extension trial of AXPAXLI (OTX-TKI) for wet age-related macular degeneration, a 36‑month open-label study designed to assess long-term safety, efficacy, and disease-modifying potential following completion of the SOL-1 or SOL-R trials. This extension study is intended to test whether earlier and sustained AXPAXLI therapy can reduce fibrosis, macular atrophy, and treatment burden compared with pulsatile anti-VEGF...

MasTec (MTZ) opened Q1 2026 with revenue of about US$3.8b and basic EPS of US$0.78, setting the tone for how the rest of the year may shape up on both the top and bottom line. Over the past six reported quarters, revenue has moved from US$3.4b in Q4 2024 to just under US$4.0b in Q3 2025 before landing at US$3.8b in the latest quarter. Quarterly basic EPS has ranged from US$0.13 in Q1 2025 to US$2.07 in Q3 2025 and stands at US$0.78 in Q1 2026. With trailing twelve month net income of...

Antero Resources reported past first-quarter 2026 results with revenue of US$1,945.13 million, net income of US$535.22 million, and record production of 3,852 MMcfe/d, alongside sharply lower property and equipment impairment charges. The company also reaffirmed its 2026 production guidance while highlighting ahead-of-schedule integration of the HG acquisition, which is already contributing to higher volumes and operational efficiencies. We’ll now examine how this record quarterly...

If you are wondering whether Rubrik's current share price reflects its true worth, this breakdown will help you connect the recent moves in the stock to what the underlying valuation signals are saying. Rubrik last closed at US$55.07, with returns of 5.3% over the past week and 13.3% over the past month, while the 1 year return sits at a 24.9% decline. Recent trading interest has been influenced by ongoing attention on data security and cloud software providers, as investors reassess how...

American Water Works Company (NYSE:AWK) has announced a proposed merger with Essential Utilities to create a large regulated U.S. water and wastewater utility. The combined business would bring together regulated water and wastewater operations across multiple states, subject to regulatory and shareholder approvals. The companies plan to integrate networks and services to serve a wider customer base under a unified regulated utility structure. For investors watching NYSE:AWK, this update...

If you are asking whether Enterprise Products Partners is still reasonably priced after a long run in the unit price, this article walks through what the current valuation really reflects and where the key pressure points are. The units last closed at US$38.03, with stated returns of 0.1% over 7 days, 1.6% over 30 days, 18.3% year to date, 33.3% over 1 year, 83.1% over 3 years and 134.3% over 5 years, which gives plenty of context for a closer look at value. Recent coverage has focused on...

If you are wondering whether Tenet Healthcare at a recent close of US$183.27 still offers value or is looking stretched, the numbers behind the share price can help frame that decision. The stock has returned 1.4% over the last 7 days, while the 30 day and year to date returns of 3.7% decline and 8.1% decline sit alongside a 23.8% return over the last year and 164.3% over 3 years. Recent coverage has focused on Tenet Healthcare's position in the US hospital and healthcare services space,...

If you are wondering whether Tyson Foods at around US$63.68 is a bargain or a value trap, the key is to look past the headline share price and into what the current valuation actually reflects. The stock has slipped about 0.5% over the last week and 1.0% over the last month, but is still showing a 9.7% return year to date and 8.5% over the last year, which can change how investors think about both opportunity and risk. Recent coverage has focused on Tyson Foods as a major player in U.S...

OrthoPediatrics (KIDS) opened Q1 2026 with revenue of US$59.4 million and a basic EPS loss of US$0.45, while trailing 12 month figures show revenue of US$243.3 million and a basic EPS loss of US$1.68 as the company continues to operate in the red. Over the past reported periods, revenue has moved from US$52.7 million in Q4 2024 to a range of roughly US$59 million to US$61.6 million through Q1 2026. Quarterly basic EPS has stayed loss making between about US$0.30 and US$0.69 per share. For...

Xcel Energy, NasdaqGS:XEL, has launched a follow on equity offering totaling $4.3b in new common stock. The company is raising a substantial amount of capital that is separate from routine earnings or guidance updates. Xcel Energy is coming to market with a large equity raise at a time when its shares last closed at $82.58. The stock has logged a 20.4% return over the past year and is up 10.6% year to date, alongside gains of 4.3% over the past week and 3.6% over the past month. For...

Federated Hermes (FHI) opened 2026 with Q1 results that put the focus squarely on its income statement, reporting total revenue of US$479 million and basic EPS of US$1.33, underpinned by net income of US$96 million. Over the past six reported quarters, revenue has ranged from US$425 million in Q1 2025 to US$483 million in Q4 2025, while quarterly basic EPS has moved between US$1.04 in Q4 2024 and US$1.39 in Q4 2025. This gives a clear view of how the current print fits into the recent run...

If you are wondering whether Qualys is starting to look like value at its current share price, or if the recent moves are a warning sign, this article walks you through what the numbers actually say. The stock last closed at US$88.53, with a 5.0% gain over the past week and a 2.7% move over the last month, set against a 32.4% decline year to date and a 30.8% decline over the past year. These returns sit alongside ongoing interest in cybersecurity providers and recurring revenue models, which...

In the first quarter of 2026, Butterfly Network, Inc. reported revenue of US$26.53 million versus US$21.23 million a year earlier, with its net loss narrowing to US$12.68 million from US$13.97 million, while also slightly improving basic and diluted loss per share from continuing operations to US$0.05 from US$0.06. Earlier in April 2026, the company appointed Arun Nagdev, MD as Chief Medical Officer – POCUS, adding deep clinical, ultrasound, and AI product expertise to guide its global...

If you are wondering whether Western Union is currently priced for opportunity or risk, this article will walk you through what the current share price might be implying about the stock's value. The stock last closed at US$9.21, with returns of 3.5% over the past week, 8.9% over the past month, 5.3% over the past year, and a small 0.2% decline year to date. This performance raises questions about how much of the story is already reflected in the price. Recent coverage around Western Union...

If you are wondering whether Cloudflare's current share price lines up with its underlying worth, this article walks through what the numbers actually say about value. With the stock at around US$217.50 and returns of 5.0% over 7 days, 5.9% over 30 days, 11.0% year to date, 75.1% over 1 year and 393.5% over 3 years, many investors are asking if the recent performance still leaves room for an attractive entry point or instead signals a higher level of risk. Recent headlines have focused on...